BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Sep 27, 2026; 18(9): 119666
Published online Sep 27, 2026. doi: 10.4240/wjgs.119666
Figure 1
Figure 1  Schematic diagram of treatment.
Figure 2
Figure 2 Gastrointestinal hormones. A: Comparison of changes in gastrin; B: Comparison of changes in motilin. aP < 0.05, bP < 0.01 vs groups. GAS: Gastrin; MTL: Motilin.
Figure 3
Figure 3 Serum inflammatory markers. A: Comparison of changes in C-reactive protein; B: Comparison of changes in interleukin-6; C: Comparison of changes in tumor necrosis factor-α. aP < 0.05, bP < 0.01, cP < 0.001 vs groups. CRP: C-reactive protein; IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α.
Figure 4
Figure 4 Quality of life. A: Comparison of changes in physical functioning; B: Comparison of changes in bodily pain; C: Comparison of changes in role-emotional; D: Comparison of changes in social functioning; E: Comparison of changes in mental health before; F: Comparison of changes in general health before. aP < 0.05, bP < 0.01 vs groups.


Write to the Help Desk